Ahead of the data readout, JMP Securities analyst Liisa Bayko upgraded Intercept from Market Perform to Market Outperform with a $175 price target. The study readout has a good chance of achieving the ...
Investing.com - Citizens JMP has reiterated its Market Outperform rating and $38.00 price target on Acadia Pharmaceuticals (NASDAQ:ACAD), currently trading at $24.76, as the company prepares to report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback